FIELD: medicine.
SUBSTANCE: invention claims treatment system for diseases affecting mucosa condition, and including immune response modifier (IRM) selected out of imidazoquinolinamines, imidazopyridinamines, cycloalcylimidazopyridinamines condensed in 6 and 7 positions, imidazonaphthyridinamines, oxazoloquinolinamines, thiazoloquinolinamines, imidazoquinolinamines with bridge link between 1 and 2 positions, pharmaceutically acceptable salts of indicated substances, and applicator for IRM effect compound application on mucosa surface. The claimed system including IRM effect compound and applicator can be applied in treatment of diseases affecting mucosa condition, such as cervical dysplasia and cervical intraepithelial neoplasia.
EFFECT: IRM delivery to mucosa.
20 cl, 8 ex, 4 tbl, 19 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT VIRAL VACCINE | 2007 |
|
RU2453335C2 |
| DERIVATIVES OF IMIDAZOLE MODULATING SODIUM CHANNEL | 2002 |
|
RU2296565C2 |
| IMMUNOMODULATOR-CONTAINING PHARMACEUTICAL FORMULATIONS | 2002 |
|
RU2327460C2 |
| COMPOSITION FOR TREATMENT OF LATENT AND SUBCLINICAL PAPILLOMAVIRUS INFECTION OF CERVIX AND METHOD FOR ITS APPLICATION | 2020 |
|
RU2747987C1 |
| NEW CONDENSED PYRROLE CARBOXYLIC ACID AMIDES: NOVEL CLASS OF LIGANDS OF BRAIN GABA-RECEPTORS | 1997 |
|
RU2167151C2 |
| PHARMACEUTICAL COMPOSITION OF PAPILLOMAVIRUS INHIBITOR | 2013 |
|
RU2661007C2 |
| SYNTHESIS OF PROTEASE INHIBITOR PRECURSOR | 2006 |
|
RU2421459C2 |
| METHOD FOR CONVERGENT SYNTHESIS OF CALICHEAMICIN DERIVATIVES | 2007 |
|
RU2436790C2 |
| SYNTHESIS OF LAMELLARINE SERIES COMPOUNDS AND ANALOGUES | 1999 |
|
RU2250209C2 |
| ARYLCARBONYLPIPERAZINES AND HETEROARYLCARBONYLPIPERAZINES FOR TUMOUR TREATMENT (VERSIONS), MEDICATION (VERSIONS), METHOD OF OBTAINING AND METHOD OF TUMOUR TREATMENT | 2003 |
|
RU2335496C2 |
